-
Blurred Lines: When Similar Symptoms Can Mean Different Things
7 min read
Latest News
-
HD Therapeutics Conference 2013 Updates: Day 3
9 min read
Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013
-
HD Therapeutics Conference 2013 Updates: Day 2
6 min read
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
-
Major Roche-Isis deal boosts Huntington's disease gene silencing
5 min read
'ASO' gene silencing drugs for HD boosted by major deal between Isis Pharmaceuticals and Roche
-
HD Therapeutics Conference 2013 Updates: Day 1
5 min read
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
-
Lost in translation? New insights into the making of the Huntington's disease protein
6 min read
Production of normal-length & extra-long huntingtin is controlled differently. A new way to keep cells healthy in HD?
-
Simple rules for a good night's sleep in Huntington's disease
7 min read
Prof Jenny Morton's simple rules for a good night's sleep in Huntington's disease
-
Is a new technique set to revolutionize Huntington's disease genetic testing?
7 min read
A new genetic testing technique for HD has been reported. What does this mean for people at risk or already tested?
-
No surprises in published results from HART study of Huntexil for Huntington's disease
3 min read
Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
-
Liver changes in Huntington's disease patients suggest more 'whole body' research needed
6 min read
A new study suggests that liver changes may occur in HD patients, opening up new avenues of research
-
The 'N17' region of huntingtin protein: an address label in Huntington's disease?
7 min read
New research sheds light on where the huntingtin protein ends up inside our cells, and why
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
